Skip to main content
. 2022 Mar 21;11(6):432–441. doi: 10.4103/EUS-D-21-00178

Table 3.

Efficacy comparison between available EUS guided ablative therapies (N is the sum of all patients from studies examining specific ablative technique; complete resolution is the sum of all patients that had this outcome in each study)

PCLs ablative technique n Complete resolution, n (%)
Paclitaxel ablation 347 221 (63.6)
Ethanol ablation 201 68 (32.8)
Lauromacrogol ablation 64 29 (45.3)
Radiofrequency ablation 30 12 (70.6)

PCLs: Pancreatic cystic lesions